Patents
Patents for C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
09/2005
09/28/2005CN1220490C Use of piperazine oxirane derivatives in preparation of medicine for inducing death of neoplastic cells
09/27/2005US6949584 use in inhibiting angiogenesis in a mammal
09/22/2005WO2005087755A1 Processes for highly enantio-and diastereoselective synthesis of acyclic epoxy alcohols and allylic epoxy alcohols
09/22/2005US20050209463 Novel compound having antitumor activity and process for producing the same
09/22/2005US20050209462 Synthesis of benzimidate from benzoic acid
09/22/2005US20050209091 Titanosilicate, process for its production, and its use in producing oxidized compound
09/21/2005EP1575928A1 Process for the manufacture of 1,2-epoxy-3-chloropropane
09/21/2005CN1671622A Microporous crystalline zeolite material (zeolite ITQ-22), synthesis method thereof and use of same as a catalyst
09/21/2005CN1219740C Epoxidation method of cis double bond
09/21/2005CN1219596C Process for prodn. of titanium-contg. silicon oxide catalysts
09/20/2005US6946566 Reacting an optically active epihalohydrin with a nucleophilic agent in the presence of a metal complex and further subjecting the compound to reaction with a base to prepare the optically active glycidyl compound
09/15/2005US20050203324 Impurity reduction in Olefin metathesis reactions
09/15/2005US20050203303 Process for the asymmetric epoxidation of olefins
09/15/2005US20050203096 Compounds to treat Alzheimer's disease
09/15/2005DE102004024709A1 Preparation of stereoisomerically enriched oxiranes, useful e.g. in preparation of pharmaceuticals and agricultural chemicals, by reacting olefin with oxidizing agent in presence of specific ruthenium catalysts
09/14/2005EP0981343B1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
09/13/2005CA2426703C Therapeutic agents and methods of use thereof for the modulation of angiogenesis
09/13/2005CA2137406C Process for key intermediates for hiv protease inhibitors
09/08/2005US20050194113 Synthetic multiple quaternary ammonium salts
09/07/2005CN1217941C Process for operating the epoxidation of ethylene
09/07/2005CN1217923C Process for preparing acid via alpha-chloroepoxy esters
09/07/2005CN1217920C Compounds to treat Alzheimer disease
09/01/2005WO2005080322A1 Fluorene derivative
09/01/2005WO2005080317A2 Therapeutic amide derivatives
09/01/2005WO2005079378A2 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
09/01/2005CA2555970A1 Therapeutic amide derivatives
09/01/2005CA2537079A1 Fluorene derivative
08/2005
08/31/2005EP1299368B1 Oxirane production method
08/31/2005CN1662518A Processes for producing epoxytriazole derivative and intermediate therefor
08/31/2005CN1216875C Method for producing epoxides by oxidising olefins
08/31/2005CN1216672C Two stage flash for hydrocarbon removal
08/30/2005US6936664 Reworkable epoxidized 1-(cyclo) alkenyl ether/polycarboxylic acid product
08/25/2005WO2005077921A1 Guanidine compound and asymmetric reaction using the same
08/25/2005WO2005077908A1 Guanidine compound and asymmetric reaction using the same
08/25/2005WO2005077463A2 Ligand for a monoamine receptor or transporter for treating addiction or dependence
08/25/2005WO2005056181A8 Gold catalyst for partial oxidation of hydrocarbon
08/25/2005US20050187410 Mesoporous material and use thereof for the selective oxidation of organic compounds
08/25/2005US20050187392 Hydrolytic kinetic resolution of cyclic substrates
08/25/2005US20050187289 Pest control compositions and methods for their use
08/25/2005US20050187110 Novel herbicides
08/24/2005EP1299349B1 Compounds to treat alzheimer's disease
08/24/2005CN1659158A Epoxidation process using a supported niobium oxide catalyst
08/24/2005CN1216048C Process for preparing propylene oxide
08/23/2005CA2153235C Compounds having selectivity for retinoid x receptors
08/18/2005WO2005056000A3 Neuroactive substance and uses of one such substance
08/18/2005US20050182148 Photosensitive adhesive composition
08/18/2005US20050181455 aryl sulfonates and sulfates used for inhibiting bioadhesion to surfaces
08/18/2005CA2555313A1 Heparanase inhibitors and uses thereof
08/17/2005CN1656076A Iminium positive ion salts in cleaning compositions
08/17/2005CN1214858C Process and device for carrying out reactions in a reactor with slot-shaped reaction spaces
08/16/2005US6930200 Mono-and di-substituted alpha-amino acid derivatives useful as raw materials for pharmaceutical and agro-chemical products
08/11/2005WO2005072868A1 A catalytic asymmetric epoxidation
08/11/2005WO2005000233A3 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
08/11/2005US20050176818 Compounds for pest control and methods for their use
08/11/2005US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors
08/10/2005EP1561750A1 Process for asymmetric epoxidation of olefins
08/10/2005EP1560649A1 Active catalysts for stereoselective ring-opening reactions
08/10/2005CN1214019C Direct epoxidation process using mixed catalyst system
08/10/2005CN1213989C New polymerisable liquid crystalline compounds
08/09/2005CA2244859C Propylene epoxidation using a silver supported catalyst
08/04/2005WO2005070877A1 Diamino alcohols and their use as renin inhibitors
08/04/2005US20050171366 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors
08/04/2005US20050171178 Exo-1-methyl-1H-imidazole-4-sulfonic acid {3-[6-ethyl-3-(2-hydroxy-indan-2-ylmethyl)-3-aza-bicyclo[3.1.0]hex-6-yl]-phenyl}-amide; opioid receptors (mu, kappa and delta) antagonists; not substrate of the variable enzyme CYP2D6; addiction to an opiates, alcohol; obesity
08/04/2005US20050171170 Clean, high-yield preparation of S,S and R,S amino acid isosteres
08/04/2005US20050169881 O(chloracetyl-carbamoyl) fumagillol -470 conjugated to hydroxypropyl(meth)acrylamide-methacrylic acid copolymer results in a water soluble composition, lowers the neurotoxicity of TNP-470, avoids penetration of TNP-470 to the cerebrospinal fluid
08/04/2005CA2553831A1 Diamino alcohols and their use as renin inhibitors
08/03/2005EP1559717A2 Oxabispidine compounds useful in the treatment of cardiac arrythmias
08/03/2005EP1309535A4 A PROCESS FOR THE PREPARATION OF $g(a)' CHLOROKETONES
08/03/2005CN1649905A Incorporable photoinitiator
08/03/2005CN1649861A Kinetics resolution method
08/03/2005CN1649858A Process for the epoxidation of olefins
08/03/2005CN1649822A Intergrated chemical processes for industrial utilization of seed oils
08/03/2005CN1649671A Ethylene oxide catalyst
08/03/2005CN1649559A Photosensitive adhesive composition
08/03/2005CN1213041C Prepn. of epoxy compounds
08/02/2005CA2170020C Retroviral protease inhibiting compounds
07/2005
07/28/2005US20050165259 Cannabinoids
07/28/2005US20050164883 agronomically tolerable salts, isomers and enantiomers of those compounds, are suitable for use as herbicides
07/27/2005EP1239956B1 Catalysts which are based on organic-inorganic hybrid materials containing noble metals and titanium and which are used for selectively oxidizing hydrocarbons
07/27/2005CN1646511A Process for the production of propylene oxide
07/27/2005CN1646510A Process for preparing alkylene oxides
07/27/2005CN1646219A Catalyst carriers
07/26/2005US6921832 Optically active fluorine-containing compounds and processes for their production
07/21/2005WO2005066197A2 Inhibitors of methionine aminopeptidase-2 and uses thereof
07/21/2005US20050159607 Catalytic asymmetric epoxidation
07/21/2005US20050159449 Cannabinoids
07/21/2005US20050158414 Subjecting birch bark to at least one of fragmentation and pelletization to provide a combination of outer birch bark shreds and inner birch bark chunks or outer birch bark pellets and inner birch bark chunks; and separating the outer birch bark sheds or outer birch bark pellets from the inner birch bark
07/21/2005DE10361157A1 Heterogeneous ruthenium catalyst, useful for hydrogenating bis-glycidyloxyphenyl-alkanes to cyclohexane analogs, for use in lacquers, has silica carrier with specific nuclear magnetic resonance characteristics
07/21/2005CA2550873A1 Inhibitors of methionine aminopeptidase-2 and uses thereof
07/20/2005EP1268457A4 Reworkable composition of oxirane(s) or thiirane(s)-containing resin and curing agent
07/20/2005CN1642637A Supported silver catalyst and an epoxidation process using the catalyst
07/20/2005CN1211376C Producing process for alcohol derivative
07/19/2005US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
07/14/2005WO2005047215A3 Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto
07/14/2005US20050154221 Having an unsaturated fatty acid or fatty ester; metathesis of the feedstock with a lower olefin; the resulting vinyl ester monomer may be epoxidized, hydroformylated or reductively aminated before oligomerization or polymerization to produce omega-epoxy, hydroxy, or amino vinyl esters
07/14/2005DE10361151A1 Heterogeneous ruthenium catalyst on silica carrier, used in ring hydrogenation of carbocyclic compound, especially bisphenol A or F bisglycidyl ether, to corresponding cycloaliphatic compound, has alkaline earth metal ions on surface
07/13/2005EP1553074A1 Fused benzene derivative and use
07/13/2005CN1639064A Titanosilicate, process for its production, and its use in producing oxidized compound
07/13/2005CN1637625A Organophotoreceptor with a charge transport material having two epoxidated-hydrazone groups
07/13/2005CN1636988A Process for preparing aryl ether
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 126